Today, I am going to cover LeMaitre Vascular (LMAT) in my "can this stock double" series. LeMaitre Vascular develops, manufactures and markets vascular devices that can treat peripheral vascular disease. The company offers a variety of products that are used by vascular surgeons and things may be looking up for the company's investors.
LeMaitre Vascular has a market cap of $102 million. In the last year the stock price of the company has appreciated by 20% and in the last 5 years it has appreciated by 122%. On the other hand, since the company's IPO in 2006, the share price has been virtually flat.
In the last couple years, the company's growth was slowing; however, things started to...
Only subscribers can access this article, which is part of the PRO research library covering 3,573 different stocks.
Growing numbers of fund managers and other investment professionals subscribe to Seeking Alpha PRO for equity research that is unavailable elsewhere, so they can: